To my followers who wonder what MOC is, and why many doctors are tweeting about it. Thread.

1) Maintenance of Certification (MOC) is a redundant requirement thrust on US physicians by a private organization. We resent it.

CD7 targetable 🎯and is expressed in ~30% of AML. Expression may change at disease progression, highlighting the need to retest. Invaluable help from super hempath Sanam Loghavi, MD صنم لغوی 🔬🧬 Sa A Wang, MD! Naval Daver, M.D. Tapan Kadia Hagop Kantarjian,MD

Read more here 👉 onlinelibrary.wiley.com/doi/10.1111/bj…

CD7 expression is linked to poor overall survival in patients with newly diagnosed acute myeloid leukemia, according to results from a retrospective study led by our Drs. Wei Ying Jen, Naval Daver, M.D. and Courtney DiNardo.

Learn more: bit.ly/44csBYw Matt Campbell MD, MS…

👉👉👉Delighted to share our recent review in ⁦ACS Journal Cancer⁩ led by Dr ⁦.Wei Ying Jen⁩ |Tagraxofusp, a first‐in‐class #CD123 ‐targeted agent:Five‐year postapproval comprehensive review of the literature #BPDCN #endcancer ⁦MD Anderson Cancer Center⁩ acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

⭐️Comprehensive review on “Tagraxofusp, a first-in-class CD123-targeted agent: Five-year postapproval comprehensive review of the literature” published in ACS Journal Cancer American Cancer Society Naveen Pemmaraju, MD Has implications in CD123-positive hematological neoplasms, including acute…

Excellent review of how tagraxofusp has changed the face of a difficult disease. Great work by Naveen Pemmaraju, MD and colleagues!

Remarkable progress in BPDCN and CD123-directed agents- great to see this highlighted by Naveen Pemmaraju, MD and colleagues!

This new review article is all about Tagraxofusp for BPDCN - ACS Journal Cancer

Wei Ying Jen, Marina Konopleva, Naveen Pemmaraju, MD

oncodaily.com/51653.html

#oncodaily #oncology #cancer #hematologicalmalignancies #Tagraxofusp #BPDCN #AML #clinicalresearch #cancer therapy

Hagop Kantarjian,MD Wei Ying Jen Marina Konopleva MD Anderson Cancer Center ACS Journal Cancer Thank you 🙏 for highlighting this important paper marking the 5-year + anniversary since the start of first #CD123 targeted agent approval and first approval in our #BPDCN field creating new avenues for clinical research. Together we will continue to innovate ! ACS Journal Cancer

Tagraxofusp is a first-in-class CD123-directed drug which has changed the field of #BPDCN . We review the evidence leading to its approval, use in combos and newer CD123 agents.
Wei Ying Jen Naveen Pemmaraju, MD Marina Konopleva MD Anderson Cancer Center #Leukemia
ACS Journal Cancer
doi.org/10.1002/cncr.3…

This new review article from Wei Ying Jen, Marina Konopleva, & Naveen Pemmaraju, MD is all about #tagraxofusp for #BPDCN . Learn how it is being used in combination to improve outcomes in BPDCN & AML, & its developing role in other hematological malignancies: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert

Factor XI deficiency: phenotypic age-related considerations and clinical approach towards bleeding risk assessment
ow.ly/qUzB50Rer3Y #FactorXI #reviewseries #thrombosisandhemostasis

Making AML fly too close to the sun
ow.ly/JIum50Reqja #myeloidneoplasia

Myelodysplastic neoplasms evolving from inherited bone marrow failure syndromes / germline predisposition syndromes… pubmed.ncbi.nlm.nih.gov/38301422/ #ContextrelevantMDS #GPS #IBMF Mayo Clinic Comprehensive Cancer Center Joseph D. Khoury, MD, FCAP

Places on Earth that don't look real - thread 🧵

1. Namibia, where the desert meets the ocean

Imposter syndrome

Pivekimab, novel CD123 antibody drug conjugate, demonstrates safety & efficacy in R-R AML.
Frontline single agent PVEK in BPDCN (CADENZA) & AZA/VEN/PVEK in frontline older #AML ongoing Naval Daver, M.D. Naveen Pemmaraju, MD MD Anderson Cancer Center
thelancet.com/journals/lanon… - The Lancet Oncology
#leusm

The one #hemepath Dx you should NEVER miss
You get it ✅: patient gets cured 👍🏻.
You get it ❌: patient dies 🪦
(I’m being dramatic.. but you get the point)
ACUTE PROMYELOCYTIC LEUKEMIA
PML::RARA
The MPO stain is your friend: blasts are strong uniform + (quick & inexpensive)…

Guide to the Diagnosis of Myeloid Neoplasms: A Bone Marrow Pathology Group Approach academic.oup.com/ajcp/article-a…

👉👉Excited to announce next Heme Reports event with focus on ASH2023 updates in ALL with our distinguished panelists (@mkonople bshah Lori Muffly Marlise R. Luskin MD, MSCE)

Kamran Mirza MD PhD - کامران مرزا Sanam Loghavi, MD صنم لغوی 🔬🧬 Naveen Pemmaraju, MD Anand Patel Nitin Jain

Tue March 5, 6.30pm CT

twitter.com/i/spaces/1nAKE…